2018 Q1 Form 10-K Financial Statement

#000142956018000004 Filed on March 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q4 2017 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.070M $5.140M $5.230M
YoY Change 3.89% 17.35% 28.19%
% of Gross Profit
Research & Development $4.600M $7.200M $10.18M
YoY Change -71.42% -77.11% -60.15%
% of Gross Profit
Depreciation & Amortization $170.0K $140.0K $190.0K
YoY Change 115.19% 100.0% 216.67%
% of Gross Profit
Operating Expenses $9.670M $12.35M $15.41M
YoY Change -53.9% -65.54% -47.98%
Operating Profit -$14.12M -$15.41M
YoY Change -60.48% -48.13%
Interest Expense -$480.0K -$550.0K $732.0K
YoY Change -183.33% 103.7% 68.66%
% of Operating Profit
Other Income/Expense, Net $930.0K $0.00 -$586.0K
YoY Change 256.32% -100.0% 115.44%
Pretax Income -$9.020M -$14.72M -$16.00M
YoY Change -56.45% -59.22% -46.49%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$9.020M -$14.72M -$16.00M
YoY Change -56.45% -59.09% -46.64%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$139.7K -$236.2K -$266.2K
COMMON SHARES
Basic Shares Outstanding 64.79M shares 62.30M shares 59.70M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.60M $66.14M $76.60M
YoY Change -37.14% -40.18% -35.95%
Cash & Equivalents $18.10M $16.60M $18.10M
Short-Term Investments $43.40M $49.54M $58.50M
Other Short-Term Assets $1.800M $1.400M $2.100M
YoY Change -37.93% -22.22% 31.25%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $63.40M $67.49M $78.68M
YoY Change -37.13% -39.95% -35.13%
LONG-TERM ASSETS
Property, Plant & Equipment $3.800M $3.805M $4.132M
YoY Change 246.72% 259.3% 490.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.400M $1.400M $1.400M
YoY Change 16.67% 16.67% 1300.0%
Total Long-Term Assets $5.200M $5.229M $5.557M
YoY Change 125.89% 130.86% 594.63%
TOTAL ASSETS
Total Short-Term Assets $63.40M $67.49M $78.68M
Total Long-Term Assets $5.200M $5.229M $5.557M
Total Assets $68.60M $72.72M $84.24M
YoY Change -33.49% -36.57% -31.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $1.424M $1.783M
YoY Change -70.29% -83.72% -74.16%
Accrued Expenses $1.500M $4.300M $3.900M
YoY Change -37.5% 59.26% 11.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.50M $12.43M $10.28M
YoY Change 219.53% 146.58% 123.54%
Total Short-Term Liabilities $15.40M $18.21M $15.99M
YoY Change 39.43% -17.39% 5.91%
LONG-TERM LIABILITIES
Long-Term Debt $12.60M $15.73M $17.78M
YoY Change -47.5% 18.5% 29.8%
Other Long-Term Liabilities $4.300M $1.104M $925.0K
YoY Change 658.38% 132.42% 32.14%
Total Long-Term Liabilities $16.90M $16.83M $18.71M
YoY Change 2880.6% 22.44% 29.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.40M $18.21M $15.99M
Total Long-Term Liabilities $16.90M $16.83M $18.71M
Total Liabilities $32.30M $38.09M $37.43M
YoY Change -9.88% 5.59% 27.32%
SHAREHOLDERS EQUITY
Retained Earnings -$357.5M -$342.8M
YoY Change 25.16%
Common Stock $392.2M $389.6M
YoY Change 7.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.30M $34.63M $46.81M
YoY Change
Total Liabilities & Shareholders Equity $68.60M $72.72M $84.24M
YoY Change -33.49% -36.57% -31.01%

Cashflow Statement

Concept 2018 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$9.020M -$14.72M -$16.00M
YoY Change -56.45% -59.09% -46.64%
Depreciation, Depletion And Amortization $170.0K $140.0K $190.0K
YoY Change 115.19% 100.0% 216.67%
Cash From Operating Activities -$10.41M -$11.81M -$11.70M
YoY Change -64.65% -57.33% -52.5%
INVESTING ACTIVITIES
Capital Expenditures -$140.0K -$110.0K -$1.370M
YoY Change -220.69% -71.05% 13600.0%
Acquisitions
YoY Change
Other Investing Activities $6.100M $8.890M $11.59M
YoY Change -10.95% 14.27% -10.78%
Cash From Investing Activities $5.950M $8.780M $10.22M
YoY Change -11.59% 18.49% -21.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.040M 1.520M 5.510M
YoY Change -64.7% -92.55% 6787.5%
NET CHANGE
Cash From Operating Activities -10.41M -11.81M -11.70M
Cash From Investing Activities 5.950M 8.780M 10.22M
Cash From Financing Activities 6.040M 1.520M 5.510M
Net Change In Cash 1.580M -1.510M 4.030M
YoY Change -128.16% -1261.54% -134.83%
FREE CASH FLOW
Cash From Operating Activities -$10.41M -$11.81M -$11.70M
Capital Expenditures -$140.0K -$110.0K -$1.370M
Free Cash Flow -$10.27M -$11.70M -$10.33M
YoY Change -65.26% -57.14% -58.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001429560
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64785659 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q2 dei Entity Public Float
EntityPublicFloat
94000000 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
TREVENA INC
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016Q4 trvn Accrued Clinical Trial Fees Current
AccruedClinicalTrialFeesCurrent
5479000 USD
CY2017Q4 trvn Accrued Clinical Trial Fees Current
AccruedClinicalTrialFeesCurrent
0 USD
CY2016Q4 trvn Accrued Development Expenses Current
AccruedDevelopmentExpensesCurrent
0 USD
CY2017Q4 trvn Accrued Development Expenses Current
AccruedDevelopmentExpensesCurrent
444000 USD
CY2015 trvn Collaboration Revenue
CollaborationRevenue
6250000 USD
CY2016 trvn Collaboration Revenue
CollaborationRevenue
3750000 USD
CY2017 trvn Collaboration Revenue
CollaborationRevenue
0 USD
CY2016Q4 trvn Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
126703000 USD
CY2017Q4 trvn Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
115918000 USD
CY2016Q4 trvn Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes
DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes
97495000 USD
CY2017Q4 trvn Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes
DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes
83707000 USD
CY2017 trvn Defined Contribution Plan Employer Match Employee Contribution Level One
DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne
0.03
CY2017 trvn Defined Contribution Plan Employer Match Employee Contribution Level Two
DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo
0.02
CY2017 trvn Defined Contribution Plan Employer Matching Contribution Percent Of Match For First Eligible Contributions
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForFirstEligibleContributions
1.00
CY2017 trvn Defined Contribution Plan Employer Matching Contribution Percent Of Match For Second Eligible Contributions
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForSecondEligibleContributions
0.50
CY2015 trvn Difference Between Basic And Diluted Net Loss Per Share
DifferenceBetweenBasicAndDilutedNetLossPerShare
0
CY2016 trvn Difference Between Basic And Diluted Net Loss Per Share
DifferenceBetweenBasicAndDilutedNetLossPerShare
0
CY2017 trvn Difference Between Basic And Diluted Net Loss Per Share
DifferenceBetweenBasicAndDilutedNetLossPerShare
0
CY2017 trvn Minimum Percentage Value Of Reverse Repurchase Agreements Collateralized By Deposits
MinimumPercentageValueOfReverseRepurchaseAgreementsCollateralizedByDeposits
1.02
CY2017Q4 trvn Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
2 plan
CY2017Q4 trvn Operating Leases Future Minimum Payments Due In Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter
9412000 USD
CY2017 trvn Operating Leases Notice Period
OperatingLeasesNoticePeriod
P90D
CY2016Q4 trvn Other Accrued Expenses And Other Current Liabilities
OtherAccruedExpensesAndOtherCurrentLiabilities
49000 USD
CY2017Q4 trvn Other Accrued Expenses And Other Current Liabilities
OtherAccruedExpensesAndOtherCurrentLiabilities
135000 USD
CY2016Q4 trvn Preferred Stock Warrant Liability Non Current
PreferredStockWarrantLiabilityNonCurrent
75000 USD
CY2017Q4 trvn Preferred Stock Warrant Liability Non Current
PreferredStockWarrantLiabilityNonCurrent
10000 USD
CY2017Q4 trvn Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
225806 shares
CY2015 trvn Stock Issued During Period Value Common Stock Warrants Net Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsNetExercised
0 USD
CY2016 trvn Stock Issued During Period Value Common Stock Warrants Net Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsNetExercised
0 USD
CY2017 trvn Tax Cutsand Jobs Actof2017 Incomplete Accounting Changein Tax Rate Provisional Income Tax Expense Benefit
TaxCutsandJobsActof2017IncompleteAccountingChangeinTaxRateProvisionalIncomeTaxExpenseBenefit
42000000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8749000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1424000 USD
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8208000 USD
CY2017Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4303000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4135000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2941000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
364148000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
392103000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3427000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
5903000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6387000 USD
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000 USD
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000 USD
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
300000 USD
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4692873 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6431428 shares
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8747314 shares
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2016Q4 us-gaap Assets
Assets
114654000 USD
CY2017Q4 us-gaap Assets
Assets
72722000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
112389000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
67493000 USD
CY2015 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-187000 USD
CY2016 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
208000 USD
CY2017 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-44000 USD
CY2016Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
18000 USD
CY2017Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
31000 USD
CY2015 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2016 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
18000 USD
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
27000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24266000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16557000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16600000 USD
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36318000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46886000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25459000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17970000 USD
CY2015 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10568000 USD
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21427000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7489000 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
123091 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10257733 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55768414 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62310795 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55768414 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62310795 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
56000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
62000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50715000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102786000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71909000 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
28500000 USD
CY2017Q4 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
100000 USD
CY2017Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
350000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
105000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
65000 USD
CY2016Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
200000 USD
CY2017Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
3100000 USD
CY2016Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
52000 USD
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
61000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
126808000 USD
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
187000 USD
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3006000 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
115983000 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15748000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16042000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1895000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3203000 USD
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
553000 USD
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
427000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
11020000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12239000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
97000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
365000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
126703000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
115918000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
105000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
65000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000 USD
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000 USD
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
400000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
208000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
246000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
490000 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.15
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.67
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.97
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.449
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.446
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.150
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.585
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8408000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3750000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3750000 USD
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1224000 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-104000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-612000 USD
CY2015 us-gaap Interest Expense
InterestExpense
334000 USD
CY2016 us-gaap Interest Expense
InterestExpense
1738000 USD
CY2017 us-gaap Interest Expense
InterestExpense
2780000 USD
CY2015 us-gaap Interest Paid
InterestPaid
155000 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.001
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.039
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.040
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.017
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.066
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.066
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.067
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2680000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2489000 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
70000 USD
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-78000 USD
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-65000 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-11000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-17000 USD
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-70000 USD
CY2015 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-8000 USD
CY2016 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-16000 USD
CY2017 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-56000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12797000 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16077000 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19639000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2821000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7130000 USD
CY2016 us-gaap Interest Paid
InterestPaid
1204000 USD
CY2017 us-gaap Interest Paid
InterestPaid
1730000 USD
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
158000 USD
CY2015 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1210000 USD
CY2016 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1334000 USD
CY2017 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
474000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
331000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
743000 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
679000 USD
CY2017Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1300000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
36073000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-29985000 USD
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2015 us-gaap Operating Expenses
OperatingExpenses
56871000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29713000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13270000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-35717000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-102283000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
38089000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114654000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72722000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22048000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18213000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
28150000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5039000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12425000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
12667000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3166000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12667000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15725000 USD
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
86335000 USD
CY2016Q4 us-gaap Marketable Securities
MarketableSecurities
86300000 USD
CY2017Q4 us-gaap Marketable Securities
MarketableSecurities
49500000 USD
CY2017Q4 us-gaap Marketable Securities
MarketableSecurities
49543000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
107582000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
32329000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
30986000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-56939000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
37798000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
32780000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-40075000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-91554000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-71255000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-50500000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-50528000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-17732000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-19295000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-35982000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-103000000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-102994000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-20714000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-20432000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-15999000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-14720000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-71900000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-71865000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50528000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-102994000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20975000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19884000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
106033000 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
70387000 USD
CY2015 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-187000 USD
CY2016 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
208000 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-71865000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
93000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-711000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1478000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-50621000 USD
CY2017 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-44000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-17749000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19104000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15413000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-14115000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-70387000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14385000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
970000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1376000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1352000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1275000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-187000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
208000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
208000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-44000 USD
CY2016Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
13000 USD
CY2017Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
11000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
475000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1104000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
174000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
222000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
614000 USD
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
180000 USD
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
534000 USD
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
1050000 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15000 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2015 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
126390000 USD
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
77421000 USD
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
62743000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
361000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
605000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3495000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
69827000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
115824000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
99018000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
906000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
256000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
361000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5194000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6746000 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1788000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1393000 USD
CY2015 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
16368000 USD
CY2016 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 USD
CY2017 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9921000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
90311000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32077000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20712000 USD
CY2017 us-gaap Revenues
Revenues
0 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1059000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3805000 USD
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3000 USD
CY2016 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
4000 USD
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44074000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89956000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48974000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1193000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1413000 USD
CY2017Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
21 employee
CY2017Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.30
CY2015 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2016 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2017 us-gaap Restructuring Charges
RestructuringCharges
1774000 USD
CY2017 us-gaap Restructuring Charges
RestructuringCharges
1800000 USD
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 USD
CY2017Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1077000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-285625000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357500000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-357490000 USD
CY2015 us-gaap Revenues
Revenues
6250000 USD
CY2016Q1 us-gaap Revenues
Revenues
1875000 USD
CY2016Q2 us-gaap Revenues
Revenues
1875000 USD
CY2016Q3 us-gaap Revenues
Revenues
0 USD
CY2016Q4 us-gaap Revenues
Revenues
0 USD
CY2016 us-gaap Revenues
Revenues
3750000 USD
CY2017Q1 us-gaap Revenues
Revenues
0 USD
CY2017Q2 us-gaap Revenues
Revenues
0 USD
CY2017Q3 us-gaap Revenues
Revenues
0 USD
CY2017Q4 us-gaap Revenues
Revenues
0 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
3427000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
5903000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
143131000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
78581000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
6387000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
34633000 USD
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32077000 USD
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20712000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
906000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
256000 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
361000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
99203000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
4000 USD
CY2017 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
501000 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
90306000 USD
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43794276 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51350365 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52174569 shares
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52205156 shares
CY2016Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53850166 shares
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52398521 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56894672 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58381868 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60113327 shares
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62290002 shares
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59436649 shares
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-indent:132px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, marketable securities and restricted cash. The Company&#8217;s investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company has no off-balance sheet concentrations of credit risk such as foreign currency exchange contracts, option contracts or other hedging arrangements.</font></div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:84px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumption that affect the amounts reported in the financial statements and accompanying notes. Management used significant estimates in the following areas, among others: stock-based compensation expense, the determination of the fair value of stock-based awards, the fair value of liability-classified common stock warrants, the accounting for research and development costs, accrued expenses and the recoverability of the Company&#8217;s net deferred tax assets and related valuation allowance. The financial data and other information disclosed in these notes are not necessarily indicative of the results to be expected for any future year or period.</font></div></div>

Files In Submission

Name View Source Status
0001429560-18-000004-index-headers.html Edgar Link pending
0001429560-18-000004-index.html Edgar Link pending
0001429560-18-000004.txt Edgar Link pending
0001429560-18-000004-xbrl.zip Edgar Link pending
a10kpipeline.jpg Edgar Link pending
chart-8cf71a557ae1c375305.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
forctrtextouttrevenaa_image1.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trvn-201710k.htm Edgar Link pending
trvn-20171231.xml Edgar Link completed
trvn-20171231.xsd Edgar Link pending
trvn-20171231_cal.xml Edgar Link unprocessable
trvn-20171231_def.xml Edgar Link unprocessable
trvn-20171231_lab.xml Edgar Link unprocessable
trvn-20171231_pre.xml Edgar Link unprocessable
trvn-2017q4ex1045.htm Edgar Link pending
trvn-2017q4ex1046.htm Edgar Link pending
trvn-2017q4ex121.htm Edgar Link pending
trvn-2017q4ex231.htm Edgar Link pending
trvn-2017q4ex311.htm Edgar Link pending
trvn-2017q4ex312.htm Edgar Link pending
trvn-2017q4ex321.htm Edgar Link pending
trvn-2017q4ex322.htm Edgar Link pending